PharmEasy in talks with SoftBank to raise $150-200 Mn at $5.6 Bn valuation
Image Credit: Inc42
API Holdings-owned Pharmeasy is in talks with SoftBank for a fund infusion of $150-200 Mn at a valuation of $5.6 Bn, according to a report by financial daily ET. The healthtech unicorn is also targeting an IPO in the next 12 to 18 months even as several consumer tech majors such as Zomato, Paytm, Delhivery, Nykaa and Ola are readying to list on the public exchanges.